Veterinary Infectious Disease Diagnostics Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report (2025-2034)
Description
The global veterinary infectious disease diagnostics market stood at a value of nearly USD 1.94 Billion in 2024. The industry is further expected to grow at a CAGR of almost 9.00% in the forecast period of 2025-2034 to reach USD 4.59 Billion by 2034. The global veterinary infectious disease diagnostics industry is being driven by the development of advanced tools for diagnosing veterinary infectious disease.
Market Segmentation
The global veterinary infectious disease diagnostics industry can be divided based on segments like technology, animal types, infection types, end-uses, and regions.
Breakup by Technology Molecular Diagnostics Polymerase Chain Reaction (PCR) Tests Microarrays Others Other Technologies Breakup by Animal Type Food-Producing Animals Cattle Swine Poultry Other Food-Producing Animals
Breakup by Infection Type
With the advancement in technology, the equipment to test and diagnose veterinary infectious disease is developing, which is aiding the industry growth. The demand for advanced diagnostic tools has increased with the increase in preference for animal-derived food products. Further, with the rising disposable incomes, especially in emerging economies, there has been a steady rise in the companion animal population and the growing adoption of pet insurance. The governments across the nations are implementing various disease control prevention measures, further creating awareness regarding the veterinary infectious disease and its treatment, which is expected to aid the industry growth over the forecast period.
The immunodiagnostics segment, among other technologies, dominated the global veterinary infectious disease diagnostics industry in 2020 owing to its advantages like early disease detection and diagnosis ability, coupled with the advancements in immunoassay formats. The reference laboratories segment is expected to account for the largest share in the industry. Region-wise, North America accounted for the largest share in the industry in 2020 owing to the increased penetration of key market players in the region.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global veterinary infectious disease diagnostics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
Market Segmentation
The global veterinary infectious disease diagnostics industry can be divided based on segments like technology, animal types, infection types, end-uses, and regions.
Breakup by Technology
- Immunodiagnostics
- Lateral Flow Assays
- Elisa Tests
- Others
- Companion Animals
- Dogs
- Cats
- Horses
Breakup by Infection Type
- Bacterial Infections
- Viral Infections
- Parasitic Infections
- Other Infections
- Reference Laboratories
- Veterinary Hospitals and Clinics
- Point-Of-Care/In-House Testing
- Research Institutes and Universities
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
With the advancement in technology, the equipment to test and diagnose veterinary infectious disease is developing, which is aiding the industry growth. The demand for advanced diagnostic tools has increased with the increase in preference for animal-derived food products. Further, with the rising disposable incomes, especially in emerging economies, there has been a steady rise in the companion animal population and the growing adoption of pet insurance. The governments across the nations are implementing various disease control prevention measures, further creating awareness regarding the veterinary infectious disease and its treatment, which is expected to aid the industry growth over the forecast period.
The immunodiagnostics segment, among other technologies, dominated the global veterinary infectious disease diagnostics industry in 2020 owing to its advantages like early disease detection and diagnosis ability, coupled with the advancements in immunoassay formats. The reference laboratories segment is expected to account for the largest share in the industry. Region-wise, North America accounted for the largest share in the industry in 2020 owing to the increased penetration of key market players in the region.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global veterinary infectious disease diagnostics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Biomerieux S.A.
- Chembio Diagnostics, Inc.
- IDEXX Laboratories, Inc.
- INDICAL BIOSCIENCE GmbH
- Neogen Corporation
- Thermo Fisher Scientific Inc.
- Others
Table of Contents
162 Pages
- 1 Executive Summary
- 1.1 Market Size 2024-2025
- 1.2 Market Growth 2025(F)-2034(F)
- 1.3 Key Demand Drivers
- 1.4 Key Players and Competitive Structure
- 1.5 Industry Best Practices
- 1.6 Recent Trends and Developments
- 1.7 Industry Outlook
- 2 Market Overview and Stakeholder Insights
- 2.1 Market Trends
- 2.2 Key Verticals
- 2.3 Key Regions
- 2.4 Supplier Power
- 2.5 Buyer Power
- 2.6 Key Market Opportunities and Risks
- 2.7 Key Initiatives by Stakeholders
- 3 Economic Summary
- 3.1 GDP Outlook
- 3.2 GDP Per Capita Growth
- 3.3 Inflation Trends
- 3.4 Democracy Index
- 3.5 Gross Public Debt Ratios
- 3.6 Balance of Payment (BoP) Position
- 3.7 Population Outlook
- 3.8 Urbanisation Trends
- 4 Country Risk Profiles
- 4.1 Country Risk
- 4.2 Business Climate
- 5 Global Veterinary Infectious Disease Diagnostics Market Analysis
- 5.1 Key Industry Highlights
- 5.2 Global Veterinary Infectious Disease Diagnostics Historical Market (2018-2024)
- 5.3 Global Veterinary Infectious Disease Diagnostics Market Forecast (2025-2034)
- 5.4 Global Veterinary Infectious Disease Diagnostics Market by Technology
- 5.4.1 Immunodiagnostics
- 5.4.1.1 Historical Trend (2018-2024)
- 5.4.1.2 Forecast Trend (2025-2034)
- 5.4.1.3 Breakup by Type
- 5.4.1.3.1 Lateral Flow Assays
- 5.4.1.3.2 Elisa Tests
- 5.4.1.3.3 Other
- 5.4.2 Molecular Diagnostics
- 5.4.2.1 Historical Trend (2018-2024)
- 5.4.2.2 Forecast Trend (2025-2034)
- 5.4.2.3 Breakup by Type
- 5.4.2.3.1 Polymerase Chain Reaction (PCR) Tests
- 5.4.2.3.2 Microarrays
- 5.4.2.3.3 Other
- 5.4.3 Other Technologies
- 5.5 Global Veterinary Infectious Disease Diagnostics Market by Animal Type
- 5.5.1 Companion Animals
- 5.5.1.1 Historical Trend (2018-2024)
- 5.5.1.2 Forecast Trend (2025-2034)
- 5.5.1.3 Breakup by Type
- 5.5.1.3.1 Animal Type
- 5.5.1.3.1.1 Dogs
- 5.5.1.3.1.2 Cats
- 5.5.1.3.1.3 Horses
- 5.5.1.3.2 Infection Type
- 5.5.1.3.2.1 Viral Infections
- 5.5.1.3.2.2 Bacterial Infections
- 5.5.1.3.2.3 Parasitic Infections
- 5.5.1.3.2.4 Other Infections
- 5.5.2 Food-Producing Animals
- 5.5.2.1 Historical Trend (2018-2024)
- 5.5.2.2 Forecast Trend (2025-2034)
- 5.5.2.3 Breakup by Type
- 5.5.2.3.1 Animal Type
- 5.5.2.3.1.1 Cattle
- 5.5.2.3.1.2 Swine
- 5.5.2.3.1.3 Poultry
- 5.5.2.3.1.4 Other Food-Producing Animals
- 5.5.2.3.2 Infection Type
- 5.5.2.3.2.1 Bacterial Infections
- 5.5.2.3.2.2 Viral Infections
- 5.5.2.3.2.3 Parasitic Infections
- 5.5.2.3.2.4 Other Infections
- 5.6 Global Veterinary Infectious Disease Diagnostics Market by End Use
- 5.6.1 Reference Laboratories
- 5.6.1.1 Historical Trend (2018-2024)
- 5.6.1.2 Forecast Trend (2025-2034)
- 5.6.2 Veterinary Hospitals & Clinics
- 5.6.2.1 Historical Trend (2018-2024)
- 5.6.2.2 Forecast Trend (2025-2034)
- 5.6.3 Point-Of-Care/In-House Testing
- 5.6.3.1 Historical Trend (2018-2024)
- 5.6.3.2 Forecast Trend (2025-2034)
- 5.6.4 Research Institutes & Universities
- 5.6.4.1 Historical Trend (2018-2024)
- 5.6.4.2 Forecast Trend (2025-2034)
- 5.7 Global Veterinary Infectious Disease Diagnostics Market by Region
- 5.7.1 North America
- 5.7.2 Europe
- 5.7.3 Asia Pacific
- 5.7.4 Latin America
- 5.7.5 Middle East and Africa
- 6 Regional Analysis
- 6.1 North America
- 6.1.1 Historical Trend (2018-2024)
- 6.1.2 Forecast Trend (2025-2034)
- 6.1.3 Breakup by Country
- 6.1.3.1 United States of America
- 6.1.3.2 Canada
- 6.2 Europe
- 6.2.1 Historical Trend (2018-2024)
- 6.2.2 Forecast Trend (2025-2034)
- 6.2.3 Breakup by Country
- 6.2.3.1 United Kingdom
- 6.2.3.2 Germany
- 6.2.3.3 France
- 6.2.3.4 Italy
- 6.2.3.5 Others
- 6.3 Asia Pacific
- 6.3.1 Historical Trend (2018-2024)
- 6.3.2 Forecast Trend (2025-2034)
- 6.3.3 Breakup by Country
- 6.3.3.1 China
- 6.3.3.2 Japan
- 6.3.3.3 India
- 6.3.3.4 ASEAN
- 6.3.3.5 Australia
- 6.3.3.6 Others
- 6.4 Latin America
- 6.4.1 Historical Trend (2018-2024)
- 6.4.2 Forecast Trend (2025-2034)
- 6.4.3 Breakup by Country
- 6.4.3.1 Brazil
- 6.4.3.2 Argentina
- 6.4.3.3 Mexico
- 6.4.3.4 Others
- 6.5 Middle East and Africa
- 6.5.1 Historical Trend (2018-2024)
- 6.5.2 Forecast Trend (2025-2034)
- 6.5.3 Breakup by Country
- 6.5.3.1 Saudi Arabia
- 6.5.3.2 United Arab Emirates
- 6.5.3.3 Nigeria
- 6.5.3.4 South Africa
- 6.5.3.5 Others
- 7 Market Dynamics
- 7.1 SWOT Analysis
- 7.1.1 Strengths
- 7.1.2 Weaknesses
- 7.1.3 Opportunities
- 7.1.4 Threats
- 7.2 Porter’s Five Forces Analysis
- 7.2.1 Supplier’s Power
- 7.2.2 Buyer’s Power
- 7.2.3 Threat of New Entrants
- 7.2.4 Degree of Rivalry
- 7.2.5 Threat of Substitutes
- 7.3 Key Indicators for Demand
- 7.4 Key Indicators for Price
- 8 Competitive Landscape
- 8.1 Supplier Selection
- 8.2 Key Global Players
- 8.3 Key Regional Players
- 8.4 Key Player Strategies
- 8.5 Company Profiles
- 8.5.1 bioMérieux SA
- 8.5.1.1 Company Overview
- 8.5.1.2 Product Portfolio
- 8.5.1.3 Demographic Reach and Achievements
- 8.5.1.4 Certifications
- 8.5.2 Chembio Diagnostics, Inc.
- 8.5.2.1 Company Overview
- 8.5.2.2 Product Portfolio
- 8.5.2.3 Demographic Reach and Achievements
- 8.5.2.4 Certifications
- 8.5.3 IDEXX Laboratories, Inc.
- 8.5.3.1 Company Overview
- 8.5.3.2 Product Portfolio
- 8.5.3.3 Demographic Reach and Achievements
- 8.5.3.4 Certifications
- 8.5.4 INDICAL BIOSCIENCE GmbH
- 8.5.4.1 Company Overview
- 8.5.4.2 Product Portfolio
- 8.5.4.3 Demographic Reach and Achievements
- 8.5.4.4 Certifications
- 8.5.5 NEOGEN Corporation
- 8.5.5.1 Company Overview
- 8.5.5.2 Product Portfolio
- 8.5.5.3 Demographic Reach and Achievements
- 8.5.5.4 Certifications
- 8.5.6 Thermo Fisher Scientific Inc.
- 8.5.6.1 Company Overview
- 8.5.6.2 Product Portfolio
- 8.5.6.3 Demographic Reach and Achievements
- 8.5.6.4 Certifications
- 8.5.7 Others
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



